A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML

NCT06329999 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Adult Acute Myeloid Leukemia
Myelodysplastic Syndrome
Adult Acute Myeloid Leukemia

Interventions

DRUG: CMGV

Sponsor

Ruijin Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]